{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:26:56Z","timestamp":1790908016423,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"vor","delay-in-days":731,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.jvs.2014.01.041","type":"journal-article","created":{"date-parts":[[2014,3,23]],"date-time":"2014-03-23T00:39:56Z","timestamp":1395535196000},"page":"1123-1133.e8","source":"Crossref","is-referenced-by-count":113,"title":["Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery"],"prefix":"10.1016","volume":"59","clinical-trial-number":[{"clinical-trial-number":"isrctn48164244","registry":"10.18810\/isrctn"},{"clinical-trial-number":"nct00120406","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00156624","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00228384","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00232843","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00232869","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00281060","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00472472","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00673985","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00715416","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00930813","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01083030","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Konstantinos","family":"Katsanos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Spiliopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayan","family":"Karunanithy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miltiadis","family":"Krokidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Sabharwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2014.01.041_bib1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2174\/157340309789317823","article-title":"Current approach to the diagnosis and treatment of femoral-popliteal arterial disease: a systematic review","volume":"5","author":"Kasapis","year":"2009","journal-title":"Curr Cardiol Rev"},{"issue":"Suppl S","key":"10.1016\/j.jvs.2014.01.041_bib2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2014.01.041_bib3","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.jvs.2011.09.001","volume":"54","author":"Rooke","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2014.01.041_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s00270-004-0029-1","article-title":"Guidelines for stenting in infrainguinal arterial disease","volume":"27","author":"Tsetis","year":"2004","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2014.01.041_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/eurheartj\/ehn514","article-title":"Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials","volume":"30","author":"Kasapis","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2014.01.041_bib6","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCINTERVENTIONS.112.969972","article-title":"Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials","volume":"5","author":"Cassese","year":"2012","journal-title":"Circ Cardiovasc Intervent"},{"key":"10.1016\/j.jvs.2014.01.041_bib7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/0272989X12458724","article-title":"Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials","volume":"33","author":"Dias","year":"2013","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jvs.2014.01.041_bib8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"379","author":"Palmerini","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2014.01.041_bib9","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2014.01.041_bib10","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"9 Pt 2","key":"10.1016\/j.jvs.2014.01.041_bib11","doi-asserted-by":"crossref","first-page":"S395","DOI":"10.1097\/01.RVI.0000094613.61428.a9","article-title":"Reporting standards for clinical evaluation of new peripheral arterial revascularization devices","volume":"14","author":"Sacks","year":"2003","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2014.01.041_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1583\/11-3627.1","article-title":"Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial","volume":"19","author":"Laird","year":"2012","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvs.2014.01.041_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468","article-title":"Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial","volume":"3","author":"Laird","year":"2010","journal-title":"Circ Cardiovasc Intervent"},{"key":"10.1016\/j.jvs.2014.01.041_bib14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCINTERVENTIONS.111.962324","article-title":"Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results","volume":"4","author":"Dake","year":"2011","journal-title":"Circ Cardiovasc Intervent"},{"key":"10.1016\/j.jvs.2014.01.041_bib15","unstructured":"Dias S, Welton NJ, Sutton AJ, Caldwell DM, Guobing L, Ades AE. NICE DSU technical support document 4: inconsistency in networks of evidence based on randomised controlled trials. 2011. Available at: http:\/\/www.nicedsu.org.uk."},{"key":"10.1016\/j.jvs.2014.01.041_bib16","unstructured":"Dias S, Welton NJ, Sutton AJ, Ades AE. NICE DSU technical support document 2: a generalised linear modelling framework for pairwise and network meta-analysis of randomized controlled trials. 2011. Available at: http:\/\/www.nicedsu.org.uk."},{"key":"10.1016\/j.jvs.2014.01.041_bib17","unstructured":"Dias S, Sutton AJ, Welton NJ, Ades AE. NICE DSU technical support document 3: heterogeneity: subgroups, meta-regression, bias and bias adjustment. 2011. Available at: http:\/\/www.nicedsu.org.uk."},{"key":"10.1016\/j.jvs.2014.01.041_bib18","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/sim.5539","article-title":"Extending methods for investigating the relationship between treatment effect and baseline risk from pairwise meta-analysis to network meta-analysis","volume":"32","author":"Achana","year":"2013","journal-title":"Stat Med"},{"key":"10.1016\/j.jvs.2014.01.041_bib19","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/0272989X13485157","article-title":"Evidence synthesis for decision making 3: heterogeneity: subgroups, meta-regression, bias, and bias-adjustment","volume":"33","author":"Dias","year":"2013","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jvs.2014.01.041_bib20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/2046-4053-1-34","article-title":"A note on the graphical presentation of prediction intervals in random-effects meta-analyses","volume":"1","author":"Guddat","year":"2012","journal-title":"Syst Rev"},{"key":"10.1016\/j.jvs.2014.01.041_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jvs.2014.01.041_bib22","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.jvs.2014.01.041_bib23","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jvs.2014.01.041_bib24","unstructured":"GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study. Available at: http:\/\/www.clinicaltrials.gov\/ct2\/show\/study\/NCT00228384. Accessed January 2013."},{"key":"10.1016\/j.jvs.2014.01.041_bib25","unstructured":"Intracoil Self-expanding Peripheral Stent. Available at: http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf\/P000033bpdf. Accessed January 2013."},{"key":"10.1016\/j.jvs.2014.01.041_bib26","article-title":"Randomized Trial of the SMART Stent versus Balloon Angioplasty in Long Superficial Femoral Artery Lesions: the SUPER Study","author":"Chalmers","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2014.01.041_bib27","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/ccd.22128","article-title":"Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions","volume":"74","author":"Dick","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2014.01.041_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.RVI.0000151260.74519.CA","article-title":"Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial","volume":"16","author":"Duda","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2014.01.041_bib29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1583\/JEVT-12-3926MR.1","article-title":"Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial","volume":"19","author":"Fanelli","year":"2012","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvs.2014.01.041_bib30","unstructured":"Lammer J. One year results of the VIASTAR trial. Presented at IROS, Berlin, Germany. Available at: http:\/\/www.esir.org. Accessed February 2013."},{"key":"10.1016\/j.jvs.2014.01.041_bib31","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jvir.2008.02.008","article-title":"Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease","volume":"19","author":"Saxon","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2014.01.041_bib32","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1161\/CIRCULATIONAHA.107.688341","article-title":"Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting","volume":"115","author":"Schillinger","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2014.01.041_bib33","unstructured":"Schmidt A. Lessons learnt from LEVANT-1 first in human study: 24-month final analysis. Available at: http:\/\/www.esir.org. Presented at CIRSE 2012. Accessed January 2013."},{"key":"10.1016\/j.jvs.2014.01.041_bib34","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2014.01.041_bib35","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","article-title":"Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial","volume":"5","author":"Werk","year":"2012","journal-title":"Circ Cardiovasc Intervent"},{"key":"10.1016\/j.jvs.2014.01.041_bib36","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.735985","article-title":"Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial","volume":"118","author":"Werk","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2014.01.041_bib37","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jacc.2013.03.034","article-title":"Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: two-year follow-up from the Zilver PTX randomized and single-arm clinical studies","volume":"61","author":"Dake","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2014.01.041_bib38","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jacc.2013.05.079","article-title":"Heparin-bonded covered stents versus bare metal stents for complex femoro-popliteal artery lesions: the randomized VIASTAR trial","volume":"62","author":"Lammer","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2014.01.041_bibe1","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2014.01.041_bibe2","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2014.01.041_bibe3","unstructured":"Dias S, Welton NJ, Sutton AJ, Caldwell DM, Guobing L, Ades AE. NICE DSU technical support document 4: inconsistency in networks of evidence based on randomised controlled trials. 2011. Available at: http:\/\/www.nicedsu.org.uk."},{"key":"10.1016\/j.jvs.2014.01.041_bibe4","unstructured":"Dias S, Welton NJ, Sutton AJ, Ades AE. NICE DSU technical support document 2: a generalised linear modelling framework for pairwise and network meta-analysis of randomized controlled trials. 2011. Available at: http:\/\/www.nicedsu.org.uk."},{"key":"10.1016\/j.jvs.2014.01.041_bibe5","unstructured":"Dias S, Sutton AJ, Welton NJ, Ades AE. NICE DSU technical support document 3: heterogeneity: subgroups, meta-regression, bias and bias adjustment. 2011. Available at: http:\/\/www.nicedsu.org.uk."},{"key":"10.1016\/j.jvs.2014.01.041_bibe6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/0272989X12458724","article-title":"Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials","volume":"33","author":"Dias","year":"2013","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jvs.2014.01.041_bibe7","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/(SICI)1097-0258(19971215)16:23<2741::AID-SIM703>3.0.CO;2-0","article-title":"Investigating underlying risk as a source of heterogeneity in meta-analysis","volume":"16","author":"Thompson","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.jvs.2014.01.041_bibe8","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/sim.5539","article-title":"Extending methods for investigating the relationship between treatment effect and baseline risk from pairwise meta-analysis to network meta-analysis","volume":"32","author":"Achana","year":"2013","journal-title":"Stat Med"},{"key":"10.1016\/j.jvs.2014.01.041_bibe9","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/0272989X13485157","article-title":"Evidence synthesis for decision making 3: heterogeneity: subgroups, meta-regression, bias, and bias-adjustment","volume":"33","author":"Dias","year":"2013","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jvs.2014.01.041_bibe10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/2046-4053-1-34","article-title":"A note on the graphical presentation of prediction intervals in random-effects meta-analyses","volume":"1","author":"Guddat","year":"2012","journal-title":"Syst Rev"},{"key":"10.1016\/j.jvs.2014.01.041_bibe11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jvs.2014.01.041_bibe12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/10618600.1998.10474787","article-title":"General methods for monitoring convergence of iterative simulations","volume":"7","author":"Brooks","year":"1998","journal-title":"J Comput Graphic Stat"},{"key":"10.1016\/j.jvs.2014.01.041_bibe13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1741-7015-11-159","article-title":"Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers","volume":"11","author":"Jansen","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.jvs.2014.01.041_bibe14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2014.01.041_bibe15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2014.01.041_bibe16","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.jvs.2014.01.041_bibe17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jvs.2014.01.041_bibe18","unstructured":"Intracoil Self-expanding Peripheral Stent. Available at: wwwaccessdatafdagov\/cdrh_docs\/pdf\/P000033bpdf. 2013."},{"key":"10.1016\/j.jvs.2014.01.041_bibe19","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa051303","article-title":"Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery","volume":"354","author":"Schillinger","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2014.01.041_bibe20","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1161\/CIRCULATIONAHA.107.688341","article-title":"Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting","volume":"115","author":"Schillinger","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2014.01.041_bibe21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCULATIONAHA.107.689141","article-title":"Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST)","volume":"116","author":"Krankenberg","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2014.01.041_bibe22","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/ccd.22128","article-title":"Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions","volume":"74","author":"Dick","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2014.01.041_bibe23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1583\/11-3627.1","article-title":"Nitinol stent implantation vs balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial","volume":"19","author":"Laird","year":"2012","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvs.2014.01.041_bibe24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468","article-title":"Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial","volume":"3","author":"Laird","year":"2010","journal-title":"Circ Cardiovasc Intervent"},{"key":"10.1016\/j.jvs.2014.01.041_bibe25","unstructured":"Mustapha J. The RESILIENT Randomized trial: three-year results. Presented at LINC 2012; 2013."},{"key":"10.1016\/j.jvs.2014.01.041_bibe26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00270-012-0492-z","article-title":"Randomized trial of the SMART Stent versus Balloon Angioplasty in Long Superficial Femoral Artery Lesions: the SUPER Study","volume":"36","author":"Chalmers","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2014.01.041_bibe27","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jvir.2008.02.008","article-title":"Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease","volume":"19","author":"Saxon","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2014.01.041_bibe28","unstructured":"GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study. Available at: http:\/\/www.clinicaltrials.gov\/ct2\/show\/study\/NCT00228384. 2013."},{"key":"10.1016\/j.jvs.2014.01.041_bibe29","unstructured":"GORE VIABAHN(r) endoprosthesis with bioactive propaten surface versus bare nitinol stent in the treatment of TASC B, C and D lesions in superficial femoral artery occlusive disease. Available at: http:\/\/www.clinical-trials.com\/ISRCTN48164244. 2013."},{"key":"10.1016\/j.jvs.2014.01.041_bibe30","unstructured":"Lammer J. One year results of the VIASTAR trial. Presented at IROS, Berlin, Germany. Available at: http:\/\/www.esir.org. 2013."},{"key":"10.1016\/j.jvs.2014.01.041_bibe31","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jacc.2013.05.079","article-title":"Heparin-bonded covered stents versus bare metal stents for complex femoro-popliteal artery lesions: the randomized VIASTAR trial","volume":"62","author":"Lammer","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2014.01.041_bibe32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.RVI.0000151260.74519.CA","article-title":"Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial","volume":"16","author":"Duda","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2014.01.041_bibe33","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/01.CIR.0000029746.10018.36","article-title":"Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results","volume":"106","author":"Duda","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2014.01.041_bibe34","unstructured":"Scheinert D. Long-term outcomes of endovascular treatment in the SFA. Presented at LINC 2011. 2013."},{"key":"10.1016\/j.jvs.2014.01.041_bibe35","first-page":"495","article-title":"Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results","volume":"4","author":"Dake","year":"2011","journal-title":"Circ CardiovascIntervent"},{"key":"10.1016\/j.jvs.2014.01.041_bibe36","doi-asserted-by":"crossref","unstructured":"Dake MD. The ZILVER-PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease: 3-year results. Vasc Intervent Adv Presented at VIVA 2012. 2012.","DOI":"10.1016\/j.jvir.2011.01.011"},{"key":"10.1016\/j.jvs.2014.01.041_bibe37","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jacc.2013.03.034","article-title":"Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: two-year follow-up from the Zilver PTX randomized and single-arm clinical studies","volume":"61","author":"Dake","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2014.01.041_bibe38","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2014.01.041_bibe39","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.735985","article-title":"Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial","volume":"118","author":"Werk","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2014.01.041_bibe40","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","article-title":"Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial","volume":"5","author":"Werk","year":"2012","journal-title":"Circ Cardiovasc Intervent"},{"key":"10.1016\/j.jvs.2014.01.041_bibe41","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1583\/JEVT-12-3926MR.1","article-title":"Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial","volume":"19","author":"Fanelli","year":"2012","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvs.2014.01.041_bibe42","unstructured":"Schmidt A. Lessons learnt from LEVANT-1 first in human study: 24-month final analysis. Available at: http:\/\/www.esir.org. Presented at CIRSE 2012. 2013."}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521414001414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521414001414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T08:25:57Z","timestamp":1716625557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521414001414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0741521414001414"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2014.01.041","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}